NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

They found that 1.4 years after these medications were stopped, the cardiometabolic markers that they looked at, such as ...

While the unmet needs of patients in Gaza are immense, new Israeli government requirements and other restrictions are ...

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with ...

Calling for greater regulation and transparency, Australian clinicians are objecting to what they consider to be restrictive ...

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain ...

A new integrated care pathway for paediatric acute asthma enhances inhaler use and key clinical documentation across primary ...

Research suggests a bidirectional relationship between posttraumatic stress disorder and fibromyalgia in military service ...

Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

A deep molecular analysis of failing human hearts suggests diabetes may directly alter cardiac metabolism, but experts differ ...

Analysis of 11 trials shows that some advanced treatments relieve symptoms faster and produce better short-term responses in ...